FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2315017051> ?p ?o ?g. }

• W2315017051 endingPage "27801" @default.
• W2315017051 startingPage "27787" @default.
• W2315017051 abstract "The mammalian target of rapamycin (mTOR) is a potentially important therapeutic target in a broad range of cancer types. mTOR inhibitors such as rapamycin and its analogs (rapalogs) have been proven effective as anticancer agents in non-small cell lung cancer (NSCLC), whereas they strongly enhance phosphorylation of eukaryotic translation initiation factor 4E (eIF4E) and activation of Akt, which cause resistance to mTOR-targeted therapy after an initial response. Rapamycin induces eIF4E phosphorylation by activating MAPK-interacting kinases (Mnks), and therefore targeting Mnk/eIF4E pathway represents a potential therapeutic strategy for the treatment of NSCLC. Here, our results showed that over-expression of p-Mnk1 and p-eIF4E was significantly associated with poor overall survival of NSCLC patients and high expression of p-Mnk1 might act as an independent prognostic biomarker for these patients. Meanwhile, inhibiting Mnk1 expression by Mnk inhibitor (CGP57380) could abrogate rapalogs (RAD001)-induced eIF4E phosphorylation and Akt activation. Furthermore, combination of CGP57380 and RAD001 could induce NSCLC cells apoptosis via activating intrinsic mitochondrial pathway, and exert synergistic antitumor efficacy both in vitro and in vivo. In conclusion, combination of targeting both mTOR and Mnk/eIF4E signaling pathways to enhance effectiveness of mTOR-targeted cancer therapy might be significant innovation for the personalized treatment of NSCLC." @default.
• W2315017051 created "2016-06-24" @default.
• W2315017051 creator A5003134390 @default.
• W2315017051 creator A5020942926 @default.
• W2315017051 creator A5028939393 @default.
• W2315017051 creator A5033738948 @default.
• W2315017051 creator A5036064136 @default.
• W2315017051 creator A5051334432 @default.
• W2315017051 creator A5061076435 @default.
• W2315017051 creator A5063534928 @default.
• W2315017051 creator A5066091339 @default.
• W2315017051 creator A5066598654 @default.
• W2315017051 date "2016-03-30" @default.
• W2315017051 modified "2023-10-18" @default.
• W2315017051 title "CGP57380 enhances efficacy of RAD001 in non-small cell lung cancer through abrogating mTOR inhibition-induced phosphorylation of eIF4E and activating mitochondrial apoptotic pathway" @default.
• W2315017051 cites W1578397386 @default.
• W2315017051 cites W1745634660 @default.
• W2315017051 cites W1752845679 @default.
• W2315017051 cites W1798025600 @default.
• W2315017051 cites W1811239105 @default.
• W2315017051 cites W1881216056 @default.
• W2315017051 cites W1953215256 @default.
• W2315017051 cites W1974404622 @default.
• W2315017051 cites W1977698143 @default.
• W2315017051 cites W1981711832 @default.
• W2315017051 cites W1986308117 @default.
• W2315017051 cites W1987835529 @default.
• W2315017051 cites W1997263291 @default.
• W2315017051 cites W1997806157 @default.
• W2315017051 cites W1998422493 @default.
• W2315017051 cites W2000263590 @default.
• W2315017051 cites W2005234434 @default.
• W2315017051 cites W2005403381 @default.
• W2315017051 cites W2011424260 @default.
• W2315017051 cites W2011961482 @default.
• W2315017051 cites W2014080468 @default.
• W2315017051 cites W2019240356 @default.
• W2315017051 cites W2031216046 @default.
• W2315017051 cites W2032666422 @default.
• W2315017051 cites W2062194875 @default.
• W2315017051 cites W2065825082 @default.
• W2315017051 cites W2071394735 @default.
• W2315017051 cites W2075062823 @default.
• W2315017051 cites W2075511135 @default.
• W2315017051 cites W2078565164 @default.
• W2315017051 cites W2079645717 @default.
• W2315017051 cites W2086546153 @default.
• W2315017051 cites W2086938346 @default.
• W2315017051 cites W2088256943 @default.
• W2315017051 cites W2100468603 @default.
• W2315017051 cites W2102148658 @default.
• W2315017051 cites W2104152920 @default.
• W2315017051 cites W2127329372 @default.
• W2315017051 cites W2140254301 @default.
• W2315017051 cites W2147168993 @default.
• W2315017051 cites W2155580728 @default.
• W2315017051 cites W2160565595 @default.
• W2315017051 cites W2162916643 @default.
• W2315017051 cites W2164521538 @default.
• W2315017051 cites W2165806251 @default.
• W2315017051 doi "https://doi.org/10.18632/oncotarget.8497" @default.
• W2315017051 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5053688" @default.
• W2315017051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27050281" @default.
• W2315017051 hasPublicationYear "2016" @default.
• W2315017051 type Work @default.
• W2315017051 sameAs 2315017051 @default.
• W2315017051 citedByCount "47" @default.
• W2315017051 countsByYear W23150170512016 @default.
• W2315017051 countsByYear W23150170512017 @default.
• W2315017051 countsByYear W23150170512018 @default.
• W2315017051 countsByYear W23150170512019 @default.
• W2315017051 countsByYear W23150170512020 @default.
• W2315017051 countsByYear W23150170512021 @default.
• W2315017051 countsByYear W23150170512022 @default.
• W2315017051 countsByYear W23150170512023 @default.
• W2315017051 crossrefType "journal-article" @default.
• W2315017051 hasAuthorship W2315017051A5003134390 @default.
• W2315017051 hasAuthorship W2315017051A5020942926 @default.
• W2315017051 hasAuthorship W2315017051A5028939393 @default.
• W2315017051 hasAuthorship W2315017051A5033738948 @default.
• W2315017051 hasAuthorship W2315017051A5036064136 @default.
• W2315017051 hasAuthorship W2315017051A5051334432 @default.
• W2315017051 hasAuthorship W2315017051A5061076435 @default.
• W2315017051 hasAuthorship W2315017051A5063534928 @default.
• W2315017051 hasAuthorship W2315017051A5066091339 @default.
• W2315017051 hasAuthorship W2315017051A5066598654 @default.
• W2315017051 hasBestOaLocation W23150170511 @default.
• W2315017051 hasConcept C104317684 @default.
• W2315017051 hasConcept C105580179 @default.
• W2315017051 hasConcept C11960822 @default.
• W2315017051 hasConcept C121608353 @default.
• W2315017051 hasConcept C126322002 @default.
• W2315017051 hasConcept C143998085 @default.
• W2315017051 hasConcept C149364088 @default.
• W2315017051 hasConcept C161295673 @default.
• W2315017051 hasConcept C184235292 @default.
• W2315017051 hasConcept C190283241 @default.
• W2315017051 hasConcept C2776256026 @default.

• next